Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
Olfactory Cleft Obstruction and Electrophysiological Olfactory Bulb Generated Beta Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
Northwestern University
30 participants
May 1, 2025
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to learn what can predict the return of the sense of smell in patients with chronic rhinosinusitis with nasal polyps being treated with dupilumab. The main questions it aims to answer are: 1. Does obstruction of the olfactory cleft predict return of the sense of smell? 2. Do electrophysiological signals generated by breathing and sniffing behavior predict return of the sense of smell? Participants starting dupilumab will undergo assessment for their degree of olfactory cleft obstruction, and an electrophysiologic assessment of their olfactory cleft and be followed over 6 months of treatment with dupilumab.
Eligibility
Inclusion Criteria4
- Well documented history of CRSwNP
- BSIT age/sex classified as "abnormal" score
- Self-reported stable olfactory deficit of moderate to severe quality \> 3 months
- Prior endoscopic sinus surgery \>3 months, \<10 years prior
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
24 weeks of dupilumab 300mg q2 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06892704